X4 Pharmaceuticals Inc
(FRA:48Q)
€
0.874
-0.006 (-0.68%)
Market Cap: 158.44 Mil
Enterprise Value: 137.33 Mil
PE Ratio: 0
PB Ratio: 159.67
GF Score: 33/100 - Q1 2024 X4 Pharmaceuticals Inc Earnings Call TranscriptMay 07, 2024€1.1 (+3.59%)Earnings
- Q4 2023 X4 Pharmaceuticals Inc Earnings Call TranscriptMar 21, 2024€0.915 (+4.57%)Earnings
- Q3 2023 X4 Pharmaceuticals Inc Earnings Call TranscriptNov 09, 2023€0.68 (-9.33%)Earnings
- X4 Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 26, 2023
- X4 Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2023
- Q2 2023 X4 Pharmaceuticals Inc Earnings Call TranscriptAug 10, 2023€1.03 (-31.79%)Earnings
- X4 Pharmaceuticals Inc 4WHIM Phase 3 Clinical Trial Update Call TranscriptMay 16, 2023
- Q1 2023 X4 Pharmaceuticals Inc Earnings Call TranscriptMay 04, 2023€1.29Earnings
- Q4 2022 X4 Pharmaceuticals Inc Earnings Call TranscriptMar 21, 2023€0.835 (+4.37%)Earnings
- X4 Pharmaceuticals Inc To Discuss Key Top-Line 4WHIM Trial Results TranscriptNov 29, 2022
- X4 Pharmaceuticals Inc at Stifel Healthcare Conference TranscriptNov 15, 2022
- Q3 2022 X4 Pharmaceuticals Inc Earnings Call TranscriptNov 03, 2022€1.95 (+3.17%)Earnings
- X4 Pharmaceuticals Inc at Canaccord Genuity Growth Conference TranscriptAug 11, 2022
- Q2 2022 X4 Pharmaceuticals Inc Earnings Call TranscriptAug 04, 2022€1.28 (+13.27%)Earnings
- Q1 2022 X4 Pharmaceuticals Inc Earnings Call TranscriptMay 12, 2022€0.985 (-7.94%)Earnings
- X4 Pharmaceuticals Inc at Canaccord Genuity Horizons in Oncology Conference (Virtual) TranscriptApr 14, 2022
- X4 Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) TranscriptApr 11, 2022
- Q4 2021 X4 Pharmaceuticals Inc Earnings Call TranscriptMar 17, 2022€1.77 (-1.12%)Earnings
- X4 Pharmaceuticals Inc at B Riley Oncology Conference (Virtual) TranscriptJan 28, 2022
- Q3 2021 X4 Pharmaceuticals Inc Earnings Call TranscriptNov 04, 2021€4.92 (+5.58%)Earnings
- X4 Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 30, 2021
- Q2 2021 X4 Pharmaceuticals Inc Earnings Call TranscriptAug 03, 2021€5.05 (+6.09%)Earnings
- Q1 2021 X4 Pharmaceuticals Inc Earnings Call TranscriptMay 06, 2021€6.55 (-5.07%)Earnings
- Q4 2020 X4 Pharmaceuticals Inc Earnings Call TranscriptMar 04, 2021€8 (+0.63%)Earnings
- X4 Pharmaceuticals Inc Dr. Ragan Discusses X4's Work To Advance Disease-Modifying Therapies For Rare Genetic Diseases TranscriptDec 23, 2020
- Q3 2020 X4 Pharmaceuticals Inc Earnings Call TranscriptNov 05, 2020€5.35 (+1.90%)Earnings
- Q2 2020 X4 Pharmaceuticals Inc Earnings Call TranscriptJul 30, 2020€6.7 (-2.90%)Earnings
- X4 Pharmaceuticals Inc Post-EHA Corporate Update TranscriptJun 12, 2020
- Q1 2020 X4 Pharmaceuticals Inc Earnings Call TranscriptMay 07, 2020€8.1 (-2.41%)Earnings
- X4 Pharmaceuticals Inc Virtual Analyst Day - A Deep Dive into WHIM Syndrome TranscriptApr 07, 2020
- Q4 2019 X4 Pharmaceuticals Inc Earnings Call TranscriptMar 12, 2020€7.46 (-5.09%)Earnings
- Q3 2019 X4 Pharmaceuticals Inc Earnings Call TranscriptNov 07, 2019Earnings
X4 Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
Sep 26, 2023 / 08:55PM GMT
Release Date Price:
€0.975
(+2.09%)
Kristen Kluska
Cantor Fitzgerald - Analyst
Okay, good afternoon, everybody. For our next presentation, I'm joined by Dr. Paula Ragan, CEO and President, and Adam Mostafa, CFO at X4 Pharmaceuticals. Welcome to our conference.
Paula Ragan
X4 Pharmaceuticals, Inc. - CEO & President
Great to be here, thank you.
Questions & Answers
Kristen Kluska
Cantor Fitzgerald - Analyst
Awesome. So, X4 is striving to be one of the pipeline in a platform stories in biotech, looking to understand how one drug candidate could potentially be impactful across a number of diseases. So, to start, could you please walk us through the role of CXCR4 has in retaining neutrophils in the blood marrow? Why is this problematic in the diseases that you're focused on?
Paula Ragan
X4 Pharmaceuticals, Inc. - CEO & President
Yeah, so CXCR4 is tied to the immune system. If folks were watching the Pfizer presentation just earlier, we wouldn't have vaccine responses or responses to
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)